Skip to main content
Premium Trial:

Request an Annual Quote

Veranome Biosystems, Portal Bioscience Form Spatial Omics Alliance

NEW YORK — Veranome Biosystems has partnered with Portal Bioscience to develop new spatial transcriptomics products for research in cancer and other complex diseases, the companies said on Thursday.

The new products will use Veranome's high-definition imaging and data analysis technologies with Portal's Proxal probe ligation-based biochemistry to enable the tracking of fragmented RNA, such as that found in formalin-fixed, paraffin-embedded specimens, as well as the detection of mutations, gene fusions, and splice variants.

Specific terms of the deal were not disclosed.

"Understanding complex tissue architectures, such as the tumor-immune microenvironment, requires robust spatial omics technologies that work on routinely fixed and paraffin-embedded clinical specimens," Ben Larman, scientific cofounder of Portal, noted in a statement

Mountain View, California-based Veranome, a spinout of Singapore's A*STAR, offers research services based on its Pisces platform for single-cell data visualization and analysis. Portal, based in Baltimore, is developing RNA analysis products based on technologies exclusively licensed from Johns Hopkins University.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.